Hertzel C. Gerstein

Is “Real World” Evidence a Reliable Way to Identify Effective Therapies?

May 26, 2017
For the CRCHUM conference taking place on June 2, 2017, Hertzel C. Gerstein, Professor of Medicine at the McMaster University, will speak about different sources of data for assessing therapeutic effectiveness, using the example of diabetes.
Lire la suite

Improving health care for mother and child, doing fewer caesareans and… saving money!

May 23, 2017
A training program to improve obstetrical management reduced the number of medically unjustified caesareans and generated significant savings for the healthcare system in Quebec (Canada), in addition to improving the quality of healthcare provided to mothers and babies.
Lire la suite
Monsef Benkirane

Finding, understanding and eliminating the HIV reservoir

May 19, 2017
For the CRCHUM conference taking place on May 26, 2017, Monsef Benkirane from the Institut de génétique humaine in France, will speak about recent discovery of his team related to HIV reservoir.
Lire la suite

$7.6M awarded to CRCHUM scientists from the Canadian Institutes of Health Research

May 18, 2017
CRCHUM scientists received 13 new Canadian Institutes of Health Research (CIHR) grants in the last Project Grant competition, the results of which were announced on May 15th.
Lire la suite

Seven researchers receive salary awards from the Fonds de recherche du Québec – Santé

May 17, 2017
The direction of the CRCHUM is proud to announce that seven of our researchers have received salary awards from the Fonds de recherche du Québec – Santé (FRQS) for 2017-2018.
Lire la suite
Paul Wheatley-Price

Update in lung Cancer treatment: Immuno-Oncology and target therapies

May 15, 2017
For the CRCHUM conference taking place on May 19, 2017, Paul Wheatley-Price, Medical Oncologist at the Ottawa Hospital, will speak about lung Cancer, its prevalence, characteristics and updates to current treatments including immunotherapy and targeted therapies.
Lire la suite
CHUM Research Centre

The CHUM’s innovative approach highlighted

May 11, 2017
The expertise of the CHUM and its research centre has once again been recognized through the new Quebec Life Sciences Strategy. This vast initiative in the area of health innovation was introduced by the Government of Quebec on May 5th.
Lire la suite

Heightened risk of heart attacks found with common painkillers in routine use

May 10, 2017
Study finds that higher risk of heart attack with common painkillers depends on dose and arises early. Doctors and patients urged to weigh the risks and benefits of ibuprofen, diclofenac, celecoxib, and naproxen.
Lire la suite
Michèle Bally

Anti-inflammatory drugs and heart attacks: what there is to know

May 10, 2017
A study published this week in The BMJ by CRCHUM’s researcher Michèle Bally found that all commonly prescribed oral non-steroidal anti-inflammatory drugs (NSAIDs) – ibuprofen, diclofenac, celecoxib, and naproxen – were associated with an increased risk of heart attack. This heightened risk of heart attack occurred as early as in the first week of use. Risk of heart attack was greater with higher doses of NSAID. Here’s what you need to know.
Lire la suite
Jef Boeke

Building synthetic chromosomes from scratch

May 8, 2017
For the CRCHUM conference taking place on May 12, 2017, Jef D. Boeke, Professor and Director at the Institute for Systems Genetics, will present a conference on the creation of synthetic yeast chromosomes.
Lire la suite